Microbicides

Other topics in this section

Microbicides: latest news

Microbicides resources

  • Microbicides

    Microbicides are any substances which protect people against infection by microbes, such as viruses or bacteria, on contact with those microbes....

    From:Preventing HIV

  • Microbicides

    A microbicide is a topical agent that, when applied to a mucosal surface, serves as a barrier to infection. Microbicides can come in the form of...

    From:HIV transmission & testing

Microbicides features

Microbicides news from aidsmap

  • Douching does not seem to increase STI risk

    Neither rectal douching nor vaginal washing appears to be as significantly associated with sexually transmitted infections or other microbial conditions that increase the risk of HIV, as had been feared, the International Microbicides Conference heard yesterday. In the case of ...

    18 April 2012 | Gus Cairns

  • Tenofovir rectal microbicide safe; may have direct effect on tissues as well as virus

    A gel containing 1% tenofovir formulated specifically for rectal use was much better tolerated than gels used in previous rectal microbicide trials when used in a safety study in 65 HIV-negative men and women, the 19th Conference on Retroviruses ...

    07 March 2012 | Gus Cairns

  • Hormonal contraception and HIV risk: no increased risk in South African cohort

    During a study of 5567 South African women, looking at the effect of hormonal contraception on HIV acquisition, 270 women became HIV-infected. The researchers report that use of hormonal contraception did not increase the risk, overall, of ...

    26 January 2012 | Carole Leach-Lemens

  • Microbicide gel fails to work in large international trial

    HIV prevention researchers and campaigners reacted with disappointment today when a trial of a tenofovir-containing microbicide gel was stopped because it had not prevented any more HIV infections than a placebo gel. The VOICE (Vaginal and Oral Interventions to Control the ...

    25 November 2011 | Gus Cairns

  • Tenofovir PrEP arm dropped in women's HIV prevention trial

    A major HIV prevention trial comparing a tenofovir microbicide with two forms of oral pre-exposure prophylaxis as HIV prevention methods for women is to halt investigation of oral tenofovir pre-exposure prophylaxis, the Microbicide Trials Network announced on Wednesday. The decision ...

    29 September 2011 | Keith Alcorn

  • The research agenda for antiretroviral prevention – now it gets complex

    We now know that starting antiretroviral therapy early, pre-exposure prophylaxis (PrEP) and vaginal microbicides can all have an impact on HIV transmission, Victor de Gruttola told a satellite session at the International AIDS Society conference (IAS 2011) in Rome on Sunday. ...

    18 July 2011 | Roger Pebody

  • Antiretroviral prevention methods 'not in competition' with each other

    Antiretroviral prevention methods are not in competition, and policy makers and providers need to start to thinking about how antiretrovirals, pre-exposure prophylaxis and microbicides will be provided as part of a combination prevention package – and who will benefit ...

    17 July 2011 | Keith Alcorn

  • Microbicide could be highly cost-effective in South African context

    A tenofovir-gel vaginal microbicide with the same efficacy as that seen in the CAPRISA 004 trial could be cost-effective in the context of the South African HIV epidemic even if only one-in-four sexually active women used it. If the gel ...

    17 July 2011 | Gus Cairns

  • Forecasters agree PrEP/microbicides could cut HIV infections in South Africa

    Several presentations at the Eighteenth Conference on Retroviruses and Opportunistic Infections this week used mathematical modelling to forecast the impact of adopting oral pre-exposure prophlyaxis (PrEP) or a topical microbicide in a high-prevalence country, added to HIV treatment or on ...

    03 March 2011 | Gus Cairns

  • First pills-versus-gel trial finds US women prefer oral PrEP

    The first head-to-head trial directly comparing the acceptability of tenofovir pills and tenofovir microbicide gel amongst HIV-negative women has found that, while African women liked both products equally, three-quarters of US women preferred a pill. The study also found, not ...

    02 March 2011 | Gus Cairns
More news

Microbicides news selected from other sources

  • Microbicides 2012 Conference: Adherence – the A-word on everyone’s lips

    In part I of this two-part blog series, Jim Pickett talks about his experiences at the recently concluded Microbicides 2012 conference in Sydney and the buzz among advocates and trial designers today.

    02 May 2012 | Mapping Pathways

  • Uganda: Nation to Test Anti-HIV Vaginal Ring

    Uganda could start testing the effectiveness of a vaginal ring to protect women against HIV infection by the end of this year, The Observer has learnt. Dubbed ASPIRE (A Study to Prevent Infection with a Ring for Extended Use), the planned two-year study seeks to determine whether a woman's use of a vaginal ring containing the antiretroviral drug Dapivirine offers effective protection against the sexual transmission of HIV.

    27 April 2012 | AllAfrica

  • Chinese researchers eye anti-AIDS gel: prevents HIV sexual transmission

    Chinese researchers said Monday they have discovered an HIV-blocking agent that could be developed into a gel to limit the sexual transmission of AIDS. The TD-0680 molecule is several times more potent than Maraviroc, a Pfizer-developed equivalent which has been approved by the Food and Drug Administration for clinical treatment, the Chinese scientists said.

    25 April 2012 | New York Daily News

  • Will women use microbicides to protect themselves against HIV?

    Miriam Hospital research on user experience with topical vaginal gels could be used to develop products that women might use more consistently to protect themselves against HIV.

    19 April 2012 | Eurekalert Medicine & Health

  • 2012 Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy Presented to Longtime Advocate Anna Forbes

    Amna Forbes, Former Deputy Director of the Global Campaign for Microbicides, wins recognition for being one on the first and longest-engaged campaigners for microbicides and for community involvement in HIV prevention research and dissewmination.

    18 April 2012 | PR Newswire

  • For how long will anal health and hygiene be neglected?

    “It is high time that anal health [and hygiene] comes out of the closet” said Dr Ross Cranston, Assistant Professor, University of Pittsburgh, USA. Dr Cranston was referring to the multitude of anal health complications people practicing receptive anal intercourse are likely to be dealing with in their lives and very little quality care and products that exist to relieve them.

    17 April 2012 | Citizen News Service

  • Rectal microbicides become a high priority in the fight against HIV in Africa

    Today IRMA (International Rectal Microbicide Advocates) will officially release "On the Map: Ensuring Africa's Place in Rectal Microbicide Research and Advocacy" at a special evening reception at the international Microbicides 2012 conference at the Sydney Convention and Exhibition Center.

    17 April 2012 | IRMA (International Rectal Microbicide Advocates)

  • European Medicines Agency issues guidance on prevention of HIV transmission for public consultation

    The paper gives recommendations on how pharmaceutical companies should study medicines for the pre-exposure prophylaxis (PrEP) of HIV. It includes information on medicines taken by mouth and on topical medicines, such as vaginal gels. It emphasises the fact that the use of PrEP should form part of an integrated approach to reducing an individual's risk of contracting HIV.

    15 March 2012 | European Medicines Agency

  • Africa: Nipple Device Could Deliver Drugs to Babies

     A simple nipple shield could help breastfeeding mothers cut the risk of HIV infection from breast milk, say researchers.

    28 February 2012 | AllAfrica

  • In Conversation with Nomita Chandhiok: Exploring the ‘tool box’ of HIV prevention strategies

    “If a woman, for whatever reason, is unable to negotiate the use of a condom during sex, at least she can have something else to protect herself with – something that can help put her in control.”

    14 February 2012 | Mapping Pathways
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.